{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:54:34Z","timestamp":1791179674545,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031601","name":"Atlas Institute for Veterans and Families","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032345","name":"St. Joseph's Healthcare Hamilton","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate the prevalence of benzodiazepine prescribing among patients with posttraumatic stress disorder (PTSD), identify patient- and practice-level correlates of benzodiazepine use, and examine the clinical rationale underlying prescribing decisions. We aimed to characterize real-world patterns and determinants of benzodiazepine use in a specialized tertiary care military and Veteran PTSD setting, where PTSD is often chronic and treatment-refractory, and to clarify the clinical factors associated with benzodiazepine prescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study using clinician-reported data from 13 psychiatrists practicing in Canadian tertiary care Operational Stress Injury clinics. Psychiatrists provided current prescribing information for 438 military personnel and Veterans receiving treatment for a primary diagnosis of PTSD. Multivariable logistic regression examined associations between patient and provider characteristics, treatment history, and benzodiazepine prescribing. Analyses adjusted for age, sex, and clinical site, and accounted for clustering at the provider level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Benzodiazepines were prescribed to 22% of patients. Use was more frequent among patients with longer PTSD duration and greater cumulative pharmacotherapy exposure. Each additional year of PTSD was associated with a 12% increase in adjusted odds of benzodiazepine use (OR 1.12, 95% CI 1.06\u20131.18). Patients with \u2265 5 years of pharmacotherapy exposure had two- to three-fold greater odds compared with those treated &amp;lt; 5 years. Benzodiazepine monotherapy was rare (&amp;lt; 1%), with most use occurring in combination with other psychotropic medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In these specialized clinics, benzodiazepine use was more common among patients with persistent illness and extensive treatment histories. These patterns suggest use occurs primarily in the context of chronic and complex care, underscoring the importance of clear clinical guidance for real-world practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1931305","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:59Z","timestamp":1791178379000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Benzodiazepine prescribing in chronic military-related PTSD: real-world patterns and correlates in specialized care"],"prefix":"10.3389","volume":"17","author":[{"given":"Erin","family":"Collins","sequence":"first","affiliation":[{"name":"MacDonald Franklin OSI Research Centre, Lawson Research Institute","place":["London, ON, Canada"]},{"name":"Department of Psychiatry, Western University","place":["London, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny J. W.","family":"Liu","sequence":"additional","affiliation":[{"name":"MacDonald Franklin OSI Research Centre, Lawson Research Institute","place":["London, ON, Canada"]},{"name":"Department of Psychiatry, Western University","place":["London, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Bilodeau","sequence":"additional","affiliation":[{"name":"Clinique TSO du CIUSSS de la Capitale Nationale","place":["Qu\u00e9bec, QC, Canada"]},{"name":"D\u00e9partement de Psychiatrie et de Neurosciences, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval","place":["Qu\u00e9bec, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Burhan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto","place":["Toronto, ON, Canada"]},{"name":"Ontario Shores Centre of Mental Health Sciences","place":["Whitby, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray W.","family":"Enns","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]},{"name":"Deer Lodge Centre OSI Clinic","place":["Winnipeg, MB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Lavoie","sequence":"additional","affiliation":[{"name":"Clinique TSO du CIUSSS de la Capitale Nationale","place":["Qu\u00e9bec, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Ein","sequence":"additional","affiliation":[{"name":"MacDonald Franklin OSI Research Centre, Lawson Research Institute","place":["London, ON, Canada"]},{"name":"Department of Psychiatry, Western University","place":["London, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Nazarov","sequence":"additional","affiliation":[{"name":"MacDonald Franklin OSI Research Centre, Lawson Research Institute","place":["London, ON, Canada"]},{"name":"Department of Psychiatry, Western University","place":["London, ON, Canada"]},{"name":"Department of Psychiatry and Behavioural Neurosciences, McMaster University","place":["Hamilton, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Auger","sequence":"additional","affiliation":[{"name":"Clinique TSO du CIUSSS de la Capitale Nationale","place":["Qu\u00e9bec, QC, Canada"]},{"name":"D\u00e9partement de Psychiatrie et de Neurosciences, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval","place":["Qu\u00e9bec, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Balderson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Western University","place":["London, ON, Canada"]},{"name":"St. Joseph\u2019s OSI Clinic, St. Joseph\u2019s Health Care London","place":["London, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Mota","sequence":"additional","affiliation":[{"name":"Deer Lodge Centre OSI Clinic","place":["Winnipeg, MB, Canada"]},{"name":"Department of Clinical Health Psychology and Psychiatry, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Wanklyn","sequence":"additional","affiliation":[{"name":"St. Joseph\u2019s OSI Clinic, St. Joseph\u2019s Health Care London","place":["London, ON, Canada"]},{"name":"Lawson Research Institute","place":["London, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Don","family":"Richardson","sequence":"additional","affiliation":[{"name":"MacDonald Franklin OSI Research Centre, Lawson Research Institute","place":["London, ON, Canada"]},{"name":"Department of Psychiatry, Western University","place":["London, ON, Canada"]},{"name":"Department of Psychiatry and Behavioural Neurosciences, McMaster University","place":["Hamilton, ON, Canada"]},{"name":"St. Joseph\u2019s OSI Clinic, St. Joseph\u2019s Health Care London","place":["London, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","volume-title":"VA\/Dod Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder","year":"2023"},{"key":"B2","unstructured":"Post-Traumatic Stress Disorder\n          \n          \n          \n          2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s42003-024-06417-w","article-title":"An ultra-short-acting benzodiazepine in thalamic nucleus reuniens undermines fear extinction via intermediation of hippocamposeptal circuits","volume":"7","author":"Cheung","year":"2024","journal-title":"Commun Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2014.02.004","article-title":"Benzodiazepine treatment can impair or spare extinction, depending on when it is given","volume":"56","author":"Hart","year":"2014","journal-title":"Behav Res Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08592","article-title":"Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder","volume":"74","author":"Rosen","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"B6","article-title":"Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need","volume":"66","author":"Otto","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/PRA.0000000000000091","article-title":"Benzodiazepines for PTSD: A systematic review and meta-analysis","volume":"21","author":"Guina","year":"2015","journal-title":"J Psychiatr Practice\u00ae"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221080464","article-title":"To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A systematic review and meta-analysis","volume":"36","author":"Campos","year":"2022","journal-title":"J Psychopharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"17m12038","DOI":"10.4088\/JCP.17m12038","article-title":"Benzodiazepines, health care utilization, and suicidal behavior in veterans with posttraumatic stress disorder","volume":"79","author":"Deka","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84318","article-title":"Suicidal ideation and suicide completion in benzodiazepine users: A systematic review of current evidence","volume":"17","author":"Khan","year":"2025","journal-title":"Cureus"},{"key":"B11","volume-title":"Veterans, Prescription Opioids and Benzodiazepines, and Mortality, 2007\u20132019: Three Target Trial Emulations","author":"Doebler","year":"2025"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3730940","article-title":"The effect of chronic alprazolam intake on memory, attention, and psychomotor performance in healthy human male volunteers","volume":"2016","author":"Chowdhury","year":"2016","journal-title":"Behav Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00178503","article-title":"Chronic use of benzodiazepines and psychomotor and cognitive test performance","volume":"88","author":"Lucki","year":"1986","journal-title":"Psychopharmacology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001209","article-title":"Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)","volume":"15","author":"Ipser","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002795.pub4","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","author":"Williams","year":"2026","journal-title":"Cochrane Database Systematic Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12888-019-2312-3","article-title":"Association between benzodiazepines and suicide risk: a matched case-control study","volume":"19","author":"Cato","year":"2019","journal-title":"BMC Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16r02037","DOI":"10.4088\/PCC.16r02037","article-title":"Prescribed benzodiazepines and suicide risk: A review of the literature","volume":"19","author":"Dodds","year":"2017","journal-title":"Primary Care Companion For CNS Disord"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113492","article-title":"An emulation of randomized trials of administrating benzodiazepines in PTSD patients for outcomes of suicide-related events","volume":"9","author":"Gilbert","year":"2020","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17lr02171","DOI":"10.4088\/PCC.17lr02171","article-title":"Benzodiazepines do not cause suicide or suicide attempts","volume":"19","author":"Rothschild","year":"2017","journal-title":"Primary Care Companion For CNS Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241294007","article-title":"Benzodiazepines for PTSD: Poor data quality and misleading advice","volume":"39","author":"Silva de Lima","year":"2025","journal-title":"J Psychopharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13582","article-title":"Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study","volume":"148","author":"Tournier","year":"2023","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109046","article-title":"Concomitant opioid and benzodiazepine use and risk of suicide attempt and intentional self-harm: Pharmacoepidemiologic study","volume":"228","author":"Gibbons","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18m12689","article-title":"New coprescription of opioids and benzodiazepines and mortality among Veterans Affairs patients with posttraumatic stress disorder","volume":"80","author":"Hawkins","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"B24","article-title":"Prescription patterns in Canadian Operational Stress Injury clinics: An in-depth examination of posttraumatic stress disorder treatment practices","author":"Liu","year":"2026","journal-title":"Primary Care Companion For CNS Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.20825","article-title":"First-line psychotherapies for military-related PTSD","volume":"323","author":"Steenkamp","year":"2020","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/09540261.2019.1595545","article-title":"Treatment of military-related post-traumatic stress disorder: challenges, innovations, and the way forward","volume":"31","author":"Forbes","year":"2019","journal-title":"Int Rev Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201100199","article-title":"Concordance between psychotropic prescribing for veterans with PTSD and clinical practice guidelines","volume":"63","author":"Jain","year":"2012","journal-title":"Psychiatr Serv"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/0706743718816057","article-title":"Comorbidity patterns of psychiatric conditions in Canadian Armed Forces personnel","volume":"64","author":"Richardson","year":"2019","journal-title":"Can J Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13333","article-title":"Benzodiazepines: Thinking outside the black box","volume":"46","author":"Pergolizzi","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000524400","article-title":"Benzodiazepines remain important therapeutic options in psychiatric practice","volume":"91","author":"Dubovsky","year":"2022","journal-title":"Psychother Psychosom"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m14128","article-title":"Deimplementation of benzodiazepine prescribing in posttraumatic stress disorder in the Veterans Health Administration","volume":"83","author":"Bernardy","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11667","article-title":"Prescribing trends in US active duty service members with posttraumatic stress disorder: A population-based study from 2007-2013","volume":"79","author":"Loeffler","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16m10904","article-title":"Usual course of treatment and predictors of treatment utilization for patients with posttraumatic stress disorder","volume":"78","author":"Nobles","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-022-00298-3","article-title":"Polypharmacy in Australian veterans with post-traumatic stress disorder upon admission to a mental health facility: A retrospective chart review","volume":"9","author":"Mellor","year":"2022","journal-title":"Drugs - Real World Outcomes"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610216000016","article-title":"Benzodiazepine use associated with co-morbid post-traumatic stress syndrome and depression in older adults seeking services in general medical settings","volume":"28","author":"Vasiliadis","year":"2016","journal-title":"Int Psychogeriatrics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201100544","article-title":"Benzodiazepine prescribing variation and clinical uncertainty in treating posttraumatic stress disorder","volume":"64","author":"Lund","year":"2013","journal-title":"Psychiatr Serv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240030","article-title":"Setting the record straight on long-term use, dose escalation, and potential misuse of prescription benzodiazepines","volume":"181","author":"Soumerai","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2020.164","article-title":"Benzodiazepines: it\u2019s time to return to the evidence","volume":"218","author":"Silberman","year":"2021","journal-title":"Br J Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-191","article-title":"General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis","volume":"14","author":"Sirdifield","year":"2013","journal-title":"BMC Fam Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxae311","article-title":"Characteristics of incident benzodiazepine recipients among US veterans with posttraumatic stress disorder","volume":"82","author":"Shahid","year":"2024","journal-title":"Am J Health Syst Pharm"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.22541\/au.160682966.66616387\/v1","article-title":"Clinical decision making regarding benzodiazepine use in PTSD treatment","author":"Bernardy","year":"2020","journal-title":"Authorea"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.10.025","article-title":"Prevalence and factors associated with polypharmacy in military and veteran populations: A systematic review and meta-analysis","volume":"369","author":"Raut","year":"2025","journal-title":"J Affect Disord"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/10398562261455779","article-title":"Prevalence and predictors of polypharmacy and psychotropic use among Australian Defence Force veterans transitioning from military to civilian life","author":"Mellor","year":"2026","journal-title":"Australas Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1037\/tra0001954","article-title":"Antipsychotic and mood stabilizer receipt for Veterans Affairs patients with PTSD: A national investigation","volume":"18","author":"Grau","year":"2026","journal-title":"psychol Trauma: Theory Research Practice Policy"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/0706743721989167","article-title":"Course and predictors of posttraumatic stress disorder in the Canadian Armed Forces: A nationally representative, 16-year follow-up study: Cours et pr\u00e9dicteurs du trouble de stress post-traumatique dans les Forces arm\u00e9es canadiennes: une \u00e9tude de suivi de 16 ans nationalement repr\u00e9sentative","volume":"66","author":"Mota","year":"2021","journal-title":"Can J Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2025.103025","article-title":"Longitudinal course of posttraumatic stress disorder and chronic pain conditions: A population-based study of Canadian military personnel over 16 years","volume":"113","author":"Asmundson","year":"2025","journal-title":"J Anxiety Disord"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2019.102133","article-title":"Examining military population and trauma type as moderators of treatment outcome for first-line psychotherapies for PTSD: A meta-analysis","volume":"67","author":"Straud","year":"2019","journal-title":"J Anxiety Disord"},{"key":"B49","article-title":"Psychiatric management of military-related PTSD: Focus on psychopharmacology","volume-title":"Post Traumatic Stress Disorders in a Global Context","author":"Richardson","year":"2012"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.48557","article-title":"Benzodiazepine discontinuation and mortality among patients receiving long-term benzodiazepine therapy","volume":"6","author":"Maust","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-025-09499-2","article-title":"Joint clinical practice guideline on benzodiazepine tapering: Considerations when risks outweigh benefits","volume":"40","author":"Brunner","year":"2025","journal-title":"J Gen Intern Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: A consensus statement of the PTSD psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1931305\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:33:01Z","timestamp":1791178381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1931305\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":52,"alternative-id":["10.3389\/fpsyt.2026.1931305"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1931305","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1931305"}}